— Know what they know.
Not Investment Advice

AREVF OTC

AREV Life Sciences Global Corp
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: -95.0% 3Y: -99.7% 5Y: -99.8%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 47 · $15881 mcap · 17M float · 0.055% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.0005-0.01
Volume10,000
Avg Volume9,333
Beta4.94
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOMichael C. Withrow
Employees19,534
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2019-04-30
18 - 91 Golden Drive
Coquitlam, BC V3K 6R2
CA
604 803 8439
About AREV Life Sciences Global Corp

AREV Life Sciences Global Corp. operates as an early-stage life science discovery company in Canada. It is involved in the extraction of compounds for consumption and topical use; clinical nutrition business; and Medicine Merchant, a technology platform. The company's pipeline products include SUS-TAINN, a superior utility supplementation therapeutic agent for indicated nutritional needs; and RES-TORE, a product based on organic plant nutrition for patients with overt clinical need for rational enhanced caloric intake and micronutrient supplementation. It also develops edible oils, moringa, hops, cannabis sativa, pharma, sea cucumber, ginseng, and functional fungi ingredients; and anti-virals and phytomedicinalization. In addition, the company flash-freezes active ingredients, oils, and oleoresins for use as ingredients in food, nutraceuticals, and other consumer products. The company was formerly known as AREV NanoTec Brands Inc. and changed its name to AREV Life Sciences Global Corp. in August 2021. AREV Life Sciences Global Corp. is based in Coquitlam, Canada.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms